PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
1.75%
Growth of 1.75% versus flat Healthcare revenue. Walter Schloss would verify growth quality.
1.74%
Cost growth of 1.74% versus flat Healthcare costs. Walter Schloss would verify cost control.
1.77%
Growth of 1.77% versus flat Healthcare gross profit. Walter Schloss would verify quality.
0.02%
Margin change of 0.02% versus flat Healthcare margins. Walter Schloss would verify quality.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-16.73%
Other expenses reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.
-0.62%
Operating expenses reduction while Healthcare median is -0.97%. Seth Klarman would investigate advantages.
1.34%
Total costs growth while Healthcare reduces costs. Peter Lynch would examine differences.
5.88%
Interest expense change of 5.88% versus flat Healthcare costs. Walter Schloss would verify control.
5.62%
D&A change of 5.62% versus flat Healthcare D&A. Walter Schloss would verify adequacy.
-29.55%
EBITDA decline while Healthcare median is 2.55%. Seth Klarman would investigate causes.
-30.76%
EBITDA margin decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
15.41%
Operating income growth exceeding 1.5x Healthcare median of 2.72%. Joel Greenblatt would investigate advantages.
13.43%
Margin change of 13.43% versus flat Healthcare. Walter Schloss would verify quality.
13.27%
Other expenses growth exceeding 1.5x Healthcare median of 0.58%. Jim Chanos would check for issues.
15.20%
Pre-tax income growth exceeding 1.5x Healthcare median of 3.18%. Joel Greenblatt would investigate advantages.
13.22%
Margin change of 13.22% versus flat Healthcare. Walter Schloss would verify quality.
18.50%
Tax expense change of 18.50% versus flat Healthcare. Walter Schloss would verify strategy.
13.61%
Net income growth exceeding 1.5x Healthcare median of 3.71%. Joel Greenblatt would investigate advantages.
11.65%
Margin change of 11.65% versus flat Healthcare. Walter Schloss would verify quality.
13.59%
EPS growth exceeding 1.5x Healthcare median of 6.58%. Joel Greenblatt would investigate advantages.
13.59%
Diluted EPS growth exceeding 1.5x Healthcare median of 6.97%. Joel Greenblatt would investigate advantages.
0.02%
Share count reduction exceeding 1.5x Healthcare median of 0.21%. Joel Greenblatt would investigate strategy.
0.02%
Diluted share reduction exceeding 1.5x Healthcare median of 0.20%. Joel Greenblatt would investigate strategy.